LY900009
产品编号: DC10926
Featured
我们的合作伙伴:
中国地区超过5000个高品质化合物库存
应用领域
(2S)-2-Hydroxy-3-methyl-N-[(2S)-1-{[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]amino}-1-oxo-2-propanyl]butanamide
Cas No.: |
209984-68-9 |
名称: |
(S)-2-hydroxy-3-methyl-N-((S)-1-(((S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)amino)-1-oxopropan-2-yl)butanamide |
别名: |
LY 900009;LY-900009 |
SMILES: |
C[C@@H](C(=O)N[C@H]1C2=CC=CC=C2C3=CC=CC=C3N(C1=O)C)NC(=O)[C@H](C(C)C)O |
分子式: |
C23H27N3O4 |
分子量: |
409.486 |
纯度: |
|
保存条件: |
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: |
|
In Vivo: |
|
In Vitro: |
|
References: |
LY900009 (LY-900009) is an orally active small molecule inhibitor of Notch signalling via selective inhibition of the γ-secretase protein, inhibits Notch signalling in tumour cell lines and endothelial cells with IC50 of 0.005-20 nM; dose dependently inhibits Notch cleavage and induced apoptosis 24 h after a single 3 mg/kg oral dose in xenograft tumour models, also demonstrates inhibition of angiogenesis through formation of leaky vasculature. |
Kinase Assay: |
|
Cell Assay: |
|
Animal Administration: |
|
References: |
|
MSDS
TITLE |
DOWNLOAD |
MSDS_654_DC10926_209984-68-9 |
|
COA
LOT NO. |
DOWNLOAD |
|
|
询盘